Monday, October 12, 2026

USD/EUR Jumps By 2% In The Last 21 Sessions

ViaNews Editorial Team

January 30, 2024

USD/EUR Jumps By 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.14% for the last 21 sessions. At 04:13 EST on Tuesday, 30 January, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 4.172% up from its 52-week low and 3.459% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was 0.09%, 0.10%, and 0.33%, respectively.

USD/EUR's highest amplitude of average volatility was 0.20% (last week), 0.22% (last month), and 0.33% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd price analysis: hovers around 1.0830 after paring intraday gains. According to FXStreet on Tuesday, 30 January, "The EUR/USD pair grapples to recover the losses registered in the previous session. ", "The significant level at 1.0850 may act as immediate resistance for the EUR/USD pair."
  • According to FXStreet on Monday, 29 January, "Another firm session of the Greenback put the risk complex under further pressure, sending the USD Index (DXY) to flirt with the upper end of the recent range and EUR/USD to the sub-1.0800 region, all amidst the emergence of usual pre-FOMC cautiousness."
  • Eur/usd finds six-week low near 1.0800 as euro broadly underperforms. According to FXStreet on Monday, 29 January, "Monday saw EUR/USD decline over eight-tenths of a percent peak-to-trough from Friday's near-term peak at 1.0886, and the pair continues to waffle below the 200-hour Simple Moving Average (SMA) descending into 1.0870.", "Technical resistance has piled up in a familiar zone just below the 1.0900 handle, capping off intraday momentum to the top side and chaining EUR/USD into a defensive position as bids test old chart territory."
  • Eur/usd weekly forecast: incremental trend lower persists as traders fret - 28 January 2024. According to DailyForex on Sunday, 28 January, "Via the results in trading of the EUR/USD it certainly appears many financial institutions believe the buying of the currency pair in December was too bullish. ", "Volatility will certainly be seen this Wednesday and the question is where support levels will hold as the price range of the EUR/USD widens before the Fed's rhetoric."
  • Eur/usd signal: broadening wedge forms ahead of fed decision - 29 January 2024. According to DailyForex on Monday, 29 January, "The EUR/USD exchange rate has moved sideways in the past few days as focus now shifts to the upcoming Fed decision. ", "The EUR/USD had an eventful week as investors reacted to several important events. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com